You may find our press releases here
- with latest information on our projects, orders, customers, cooperations and other activitie
You may find our press releases here - with latest information on our projects, orders, customers, cooperations and other activities.
16.01.2025
adesso Top Employer 2025 in Germany for the first time
IT service provider adesso is one of more than 160 companies surveyed nationwide that have been awarded the Top Employers Institute’s
“Top Employer 2025 in Germany” seal of approval. This positions the digitalisation partner of numerous private and public organizations as one of the top employers in the German IT industry. adesso particularly impressed the auditors with its outstanding performance in talent acquisition, onboarding, work environment as well as learning and development.
14.01.2025
Lean meets Digital: adesso provides impetus for the production of the future
The comprehensive use of data, the digitalisation of processes and AI-based assistance systems are paving the way for lean, integrated production systems – a basic prerequisite for increasing productivity and competitiveness.
18.12.2024
Innovation or dead end? The truth about GenAI projects
Statement on the topic of GenAI projects
17.12.2024
Intelligent prevention: adesso ventures supports Noah Labs in relieving the burden on heart specialists
The most common cause of hospitalisation in western industrialised nations? Cardiovascular diseases. The financial burden of cardiovascular patients on healthcare systems is enormous. Noah Labs co-founders Oliver Piepenstock, Marcus Hott, and Dr Leonhard Riehle are dedicated to alleviating the workload of cardiology practices and hospitals in Germany through AI-supported telemonitoring, while simultaneously enhancing the care provided to patients. The Noah Labs Ark software and the associated intelligent Connected Care platform enable comprehensive remote monitoring and management of chronic diseases based on classic vital parameters. The focus of the current application is on heart failure. However, high blood pressure and cardiac arrhythmia can also be monitored with the software. The solution received approval as a Class IIa medical device in accordance with the EU Medical Device Directive (MDR) in April 2024 and is already in use in numerous practices and clinics.
Do you have any questions?
Do you have any questions about our press service or a specific request? Please contact us.
PR-Manager Nils Roos +491704406148 nils.roos@adesso.de